UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Screening Tests for Sarcopenia in Patients with Chronic Kidney Disease

Jiang, K; Slee, A; Davenport, A; (2021) Screening Tests for Sarcopenia in Patients with Chronic Kidney Disease. Nutrition in Clinical Practice , 36 (5) pp. 1049-1052. 10.1002/ncp.10597. Green open access

[thumbnail of Davenport_REVISEDredSarcFpaperNutrClinPract.pdf]
Preview
Text
Davenport_REVISEDredSarcFpaperNutrClinPract.pdf - Accepted Version

Download (105kB) | Preview

Abstract

Background: Patients with chronic kidney disease (CKD) are at increased risk of muscle wasting. Screening tools for sarcopenia, including the Sarc-F questionnaire are now advocated for clinical practice. We wished to compare using the Sarc-F tool with standard measurements of hand grip (HGS) strength and appendicular muscle mass index (APMI). Methods: We retrospectively reviewed Sarc-F questionnaires completed by patients with CKD, along with contemporaneous measurements of HGS and bioimpedance measured APMI. Results: 146 patients; 94 male (64.4%), mean age 70.5 ± 15 years, body mass index 28.7 ± 6.3 kg/m2 were screened, and 46 screened positive for sarcopenia, with a lower median HGS (19.3 (14.2–24.7) vs 25.6 (19.7–32) kg) and greater body fat (38.3 ± 11.5 vs 30.6 ± 11.5%), both p < 0.001,, with more non-white ethnicity (63 vs 44%), p < 0.05, but there were no other differences. Step-wise adding HGS, and then APMI cut offs, the prevalence of sarcopenia fell from 31.5% to 20.7–24.7% and 2.8–4.8% respectively, with 45.5–62.8% having reduced HGS strength and 11.0–28.1% reduced APMI, depending on which guidelines were applied. Using the most recent European, and ethnicity adjusted cut-off values then there were no statistical differences in the prevalence of sarcopenia with or without the Sarc-F screening tool. Conclusions: By starting with the Sarc-F screening tool, a number of our patients with CKD would then have been excluded from subsequent investigation for sarcopenia. However, overall screening with the Sarc-F tool did not lead to a significant difference in the prevalence of sarcopenia, when using current and ethnicity adjusted guidelines, compared to combining HGS and APMI alone.

Type: Article
Title: Screening Tests for Sarcopenia in Patients with Chronic Kidney Disease
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/ncp.10597
Publisher version: https://doi.org/10.1002/ncp.10597
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Science & Technology, Life Sciences & Biomedicine, Nutrition & Dietetics, bioimpedance, chronic kidney disease, hand grip strength, muscle mass, nutrition assessment, nutrition screening, sarcopenia, BODY-COMPOSITION, CONSENSUS
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Department of Education
URI: https://discovery.ucl.ac.uk/id/eprint/10135474
Downloads since deposit
254Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item